| Companies sponsors |
Autolus (obecabtagene autoleucel) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Anthony Nolan |
| |
Leukaemia UK |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Associated public health groups |
None |
| Comparator companies |
AAH Pharmaceuticals (dasatinib, imatinib) (confidentiality agreement not signed, not participating) |
| |
Accord UK (cytarabine, filgrastim, fludarabine, imatinib, pegfilgrastim) (confidentiality agreement not signed, not participating) |
| |
Amarox (imatinib) (confidentiality agreement not signed, not participating) |
| |
Amgen (blinatumomab, filgrastim, pegfilgrastim) (confidentiality agreement not signed, not participating) |
| |
Aurobindo (Milpharm) (imatinib) (confidentiality agreement not signed, not participating) |
| |
Chugai Pharma UK Ltd (lenograstim) (confidentiality agreement not signed, not participating) |
| |
Cipla EU (imatinib) (confidentiality agreement not signed, not participating) |
| |
Dr. Reddy’s Laboratories (imatinib) (confidentiality agreement not signed, not participating) |
| |
Hospira UK (cytarabine) (confidentiality agreement not signed, not participating) |
| |
Incyte Biosciences UK (ponatinib) (confidentiality agreement not signed, not participating) |
| |
Mylan (dasatinib) (confidentiality agreement not signed, not participating) |
| |
Napp Pharmaceuticals (pegfilgrastim) (confidentiality agreement not signed, not participating) |
| |
Novartis (imatinib, tisagenlecleucel) (confidentiality agreement signed, participating) |
| |
Pfizer (cytarabine, filgrastim, idarubicin, inotuzumab ozogamicin) (confidentiality agreement not signed, not participating) |
| |
Sandoz (dasatinib, filgrastim, imatinib, pegfilgrastim) (confidentiality agreement not signed, not participating) |
| |
Sanofi (fludarabine) (confidentiality agreement not signed, not participating) |
| |
Teva UK (dasatinib, fludarabine, lipegfilgrastim) (confidentiality agreement not signed, not participating) |
| |
Viatris UK Healthcare (dasatinib)(confidentiality agreement not signed, not participating) |
| |
Zentiva (dasatinib) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health – Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |